Betts, Brian C <br/><br/>
Anti-IL6-receptor-alpha (tocilizumab) does not inhibit human monocyte-derived dendritic cell maturation or alloreactive T-cell responses.  [electronic resource] 

 -  Blood  Nov 2011 
 - 5340-3 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1528-0020 
<br/><br/><label>Standard No.: </label>10.1182/blood-2011-06-363390  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antibodies, Monoclonal, Humanized--pharmacology<br/>Cell Differentiation--immunology<br/>Dendritic Cells--cytology<br/>Graft vs Host Disease--immunology<br/>Humans<br/>In Vitro Techniques<br/>Isoantigens<br/>Janus Kinase 2--immunology<br/>Mice<br/>Receptors, Interleukin-6--antagonists & inhibitors<br/>STAT3 Transcription Factor--immunology<br/>Signal Transduction--immunology<br/>T-Lymphocytes--immunology<br/>T-Lymphocytes, Regulatory--immunology<br/>Th17 Cells--immunology